DNTHMagenta TherapeuticsDNTH info
$26.00info0.04%24h
Global rank13081
Market cap$385.26M
Change 7d-12.52%
YTD Performance152.92%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Magenta Therapeutics (DNTH) Stock Overview

    Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. It develops DNTH103 that is in phase 1 clinical trails in patients with generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was incorporated in 2015 and is based in New York, New York.

    DNTH Stock Information

    Symbol
    DNTH
    Address
    7 Times SquareNew York, NY 10036United States
    Founded
    -
    Trading hours
    -
    Website
    https://dianthustx.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    929-999-4055

    Magenta Therapeutics (DNTH) Price Chart

    -
    Value:-

    Magenta Therapeutics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $26.00
    N/A
    Market Cap
    $385.26M
    N/A
    Shares Outstanding
    14.82M
    N/A
    Employees
    32.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org